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Bacillus cereus is a Gram-positive rod that is now recognized as a rare cause of frank disease in the neutropenic hematologic
malignancy patient. Because this pathogen is rarely isolated in clinical specimens, no large studies exist to guide the management
of these acutely ill patients. Individual case reports and case series exist in the literature describing various clinical manifestations
of B. cereus in the neutropenic patient including bacteremia/septicemia, pneumonia, meningitis/encephalitis, hepatic abscesses,
and gastritis. In this report, we describe a case of typhlitis caused by B. cereus in a 74-year-old female with recently diagnosed acute
myelogenous leukemia (AML), and we summarize the available English language literature to draw tentative conclusions regarding the clinical manifestations of this organism.

1. Background
Bacillus cereus is a Gram-positive, spore-forming rod that
classically causes food poisoning via plasmid-encoded toxins.
Life-threatening infections with B. cereus have been reported
in patients with hematologic malignancies, primarily as these
patients experience neutropenia following the initiation of
induction chemotherapy. Here, we report a case of B. cereus
colitis/typhlitis in a neutropenic patient with acute myelogenous leukemia (AML), and we summarize the literature
regarding the infectious manifestations of B. cereus in patients
with hematologic malignancies. This is the second reported
case of B. cereus typhlitis.

2. Case Report
A 74-year-old Caucasian female with a 2-month history of
pancytopenia and a preliminary diagnosis of myelodysplastic
syndrome (MDS) presented to our tertiary cancer treatment
facility for further evaluation. A repeat bone marrow biopsy
was performed and demonstrated 26% blasts, and the patient
was formally diagnosed with acute myelogenous leukemia

(AML). One month later, the patient was admitted to our
facility for induction “7 + 3” chemotherapy with sorafenib.
On admission, the patient was found to have mild pancytopenia with an absolute neutrophil count (ANC) between
500 and 1,000 cells/μL but had no speciﬁc complaints and an
unremarkable physical examination.
Following initiation of chemotherapy, antimicrobial
prophylaxis with ciproﬂoxacin, acyclovir, and micafungin
was begun, and nebulized amphotericin B was added because
computed tomography (CT) scan of the chest demonstrated
several ground-glass inﬁltrates with no pulmonary symptoms.
The ground-glass inﬁltrates remained stable on follow-up
CT scan. Mild hemoptysis developed and empiric cefepime was begun in place of oral ciproﬂoxacin on the 8th
day of neutropenia due to fever. She remained stable and
well appearing until the 10th day of neutropenia when
nonbloody diarrhea without abdominal pain developed.
Clostridium diﬃcile stool polymerase chain reaction (PCR)
analysis was negative. Loperamide was administered to
help reduce the diarrhea.
Diarrhea persisted despite escalating doses of loperamide, and on the 13th day of neutropenia, right upper
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Table 1: Summary of literature review ﬁndings.

Reference Number

Author

[5]

Uchino et al.

[6]

Frankard et al.

[7]

Marley et al.

[8]

Le Scanﬀ et al.

[9]

Inoue et al.

[10]

Ginsburg et al.

[11]

Musa et al.

[12]

Akiyama et al.

Summary
This article reports 13 cases of septicemia caused by B. cereus. Uchino et al. report
a case fatality rate of 25% and found that the presence of liver and CNS involvement
portended a poorer prognosis. Clindamycin resistance was found to be high in this
series (76.9%), and Uchino et al. recommend against using clindamycin and
carbapenems in the empiric treatment of B. cereus infections.
This article reports a case of pneumonia caused by B. cereus in the context of
a neutropenic patient with ALL. This patient was treated with VCN and
demonstrated clinical improvement. She was readmitted 3 weeks later with
a recurrent pneumonia due to Streptococcus spp., and she expired due to this later
infection.
Marley et al. report a case of meningoencephalitis occurring in a patient undergoing
induction chemotherapy for AML. The patient became febrile with an ANC of
20/mm3. Over several hours, the patient experienced a rapid deterioration of
mentation, and a CT scan revealed multiple enhancing lesions in the brain. The
patient died 12 hours following the onset of neurological symptoms. Autopsy
additionally found multiple liver abscesses.
Le Scanﬀ et al. report a case of necrotizing gastritis in a female patient with AML 63
days following induction chemotherapy initiation. The patient developed severe
epigastric pain and massive hematemesis leading to hemodynamic instability;
blood and gastric mucosal cultures revealed B. cereus. This patient was successfully
treated with combination of VCN and imipenem.
This substantial article reports 23 cases of B. cereus bacteremia in HM patients, with
12 of these patients developing a frank sepsis. Inoue reports a case fatality rate of
25% for B. cereus sepsis. Further, independent risk-factor analysis concluded that
a low ANC, CV catheterization, and CNS symptoms were all signiﬁcantly
associated with a poorer prognosis.
Ginsburg et al. report a fatal case of B. cereus sepsis that arose in a 22-year-old male
following induction chemotherapy for AML. On hospital day 5, the patient became
febrile and neutropenic and a CT scan revealed ﬁndings consistent with colitis, but
stool C. diﬃcile testing remained negative. His symptoms resolved by hospital day
14 with metronidazole and imipenem. However, 6 days later, he developed diﬀuse
abdominal pain and blood cultures revealed B. cereus. VCN and ampicillin were
added, but a new CT revealed pancolitis and multiple hypodense lesions in the liver.
The patient expired on the thirty-fourth hospital day. Autopsy conﬁrmed the
presence of B. cereus in the liver microabscesses.
This case series describes 3 patients, 2 with AML and 1 with ALL, who develop
septicemia due to B. cereus. All 3 patients died despite treatment with amikacin.
Additionally, all 3 patients developed a similar syndrome of abnormal posturing
and clinical signs of brain stem death. 1 patient in this case series was found to have
elevated liver enzymes and serum bilirubin perimortem.
Akiyama et al. report a case of fatal B. cereus septicemia in a 64-year-old patient
with AML undergoing induction chemotherapy. Autopsy revealed a necrotizing
infection in the leptomeninges of the brain and spinal cord and numerous
microabscesses of the liver. B. cereus was present within these lesions.

CNS � central nervous system; ALL � acute lymphoblastic leukemia; VCN � vancomycin; AML � acute myelogenous leukemia. ANC � absolute neutrophil
count. CT �computed tomography. HM � hematologic malignancy. CV � central venous. C. diﬃcile � Clostridium diﬃcile.

quadrant abdominal pain developed and metronidazole
500 mg twice daily was initiated. CT scan of the abdomen
and pelvis revealed cecal wall thickening associated with
fat stranding and right paracolic gutter ﬂuid collection—
ﬁndings consistent with typhlitis. Labs revealed an ANC of less
than 500 cells/μL. Stool cultures obtained the following day
revealed a preponderance of Bacillus cereus with the absence
of usual enteric ﬂora. Physical examination then demonstrated dull periumbilical pain upon palpation and a sharper
pain in the right lower quadrant of the abdomen. Metronidazole was changed to clindamycin 450 mg thrice daily.
During the next several days, the abdominal pain and diarrhea resolved. The patient’s later hospital course was

complicated by vancomycin-resistant Enterococcus (VRE)
bacteremia that developed after 21 days of neutropenia and
was treated with central venous catheter removal and linezolid 600 mg twice per day. She would ﬁnish the 2-week
linezolid course outpatient; she was discharged afebrile after
30 hospital days with an ANC of 3.28 cells/μL. Complete
clinical remission of the AML was ultimately achieved
following 2 rounds of consolidation chemotherapy.

3. Discussion
Typhlitis, also known as neutropenic enterocolitis (or, rarely,
ileocecal syndrome) is the most common cause of fever and
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Table 2: Conclusions for Bacillus cereus infection in neutropenic hematologic malignancy patients.

1
2
3
4

Conclusion
Neutropenia is the primary risk factor for infection, as opposed to
intoxication, with B. cereus
B. cereus has a predilection for the CNS and the liver; involvement
of either of these two organ systems portends a poor prognosis
The case fatality rate for B. cereus sepsis appears to be 25%
The most commonly used deﬁnitive therapy for B. cereus infection
appears to be vancomycin with or without carbapenem

Reference Number
[5–12]
[5, 7, 9–12]
[5, 9]
[5–10]

CNS � central nervous system.

abdominal tenderness in the neutropenic patient [1]. Historically, Clostridium septicum was pointed to as a common
etiologic agent of typhlitis [2]. It is known, however, that the
microbiologic etiology of this disease is broad and diverse,
with an 18-year study in leukemic children ﬁnding that 84%
and 16% of cases being caused by bacteria and fungi, respectively [3]. Currently, there exist no high-quality casecontrol, cohort, or randomized controlled trials to guide
clinicians in the best management of typhlitis [4].
The isolation of B. cereus from clinical specimens was
historically considered contamination. However, it is now
clear from the literature that B. cereus can cause a wide
spectrum of disease in the neutropenic patient. Our patient,
a 74-year-old female undergoing induction chemotherapy
for AML, was found to have typhlitis with stool culture
conﬁrming the presence of B. cereus in the colon with
a notable absence of the usual enteric ﬂora. The initiation of
clindamycin led to a rapid improvement in our patient’s
symptoms. Our patient’s blood cultures remained sterile
during the episode of typhlitis.
On review of the literature, we found a handful of reports
describing the various clinical manifestations of B. cereus
(Table 1). The most common manifestation was sepsis. As
reported by Uchino et al., patients who develop central
nervous system (CNS) symptoms or who have bacterial involvement of the liver tend to have a worse prognosis [5, 9].
Indeed, from our review, it is clear that while B. cereus
bacteremia can result in the seeding of almost any organ,
B. cereus seems to preferentially seed the brain/meninges and
the liver [5, 7, 9–12]. CNS involvement is most commonly
multifocal and leads to a rapid deterioration in mental status
and frequently leads to development of a comatose state. Liver
involvement is often asymptomatic but can manifest on CT
scan as multiple subcentimeter, hypodense lesions. Pathologic analysis of the liver at autopsy reveals microabscesses
with large Gram-positive rods present within the lesions
[10, 12].
The management of the neutropenic patient with cultures positive for B. cereus presents a clinical dilemma as no
large studies exist to guide the management of these critically
ill patients. From our review of the available English language literature, some tentative conclusions may be drawn
regarding this organism in the context of the neutropenic
hematologic malignancy patient. These conclusions are
summarized in Table 2.
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